[1]
C. M. Herndon, PharmD, T. R. Kirby, PharmD, K. J. Madison, PharmD, and J. L. Kerr, PharmD, CDCES, “Comparison of the Centers for Disease Control (CDC) recommendations and the risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) tool for guiding naloxone coprescribing”, J of Opioid Management, vol. 19, no. 2, pp. 111–116, Mar. 2023.